Kestra Medical Technologies, Ltd. (KMTS)
Who owns Kestra Medical Technologies, Ltd. (KMTS)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 55.7% of the shares are freely tradable; institutional investors hold 102.9%.
Ownership Structure
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Bain Capital Investors LLC | 42.95 | 25,172,338 | +0.0 | 03/31/2026 |
| T. Rowe Price Associates, Inc. | 10.18 | 5,968,664 | +36.6 | 03/31/2026 |
| FMR Inc | 9.76 | 5,721,054 | -2.2 | 03/31/2026 |
| Andera Partners | 4.66 | 2,728,679 | +1.2 | 06/30/2026 |
| Yu Fan | 3.89 | 2,282,519 | +0.0 | 03/31/2026 |
| Brown Advisory Holdings Inc | 2.94 | 1,723,730 | +2.1 | 03/31/2026 |
| BlackRock Inc | 2.88 | 1,689,247 | +36.8 | 03/31/2026 |
| Eventide Asset Management, LLC | 2.47 | 1,445,864 | +13.9 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| US Small-Cap Growth II Equity Comp | 4.17 | 2,443,527 | -5.7 | 06/30/2026 |
| T. Rowe Price New Horizons | 4.17 | 2,443,527 | -5.7 | 06/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 16. Jul 2026 | Moran Timothy P. | Chief Business Officer | Other | 39,113 | 0.00 | – |
| 15. Jul 2026 | Ford Alfred J Jr | Chief Commercial Officer | Other | 58,832 | 0.00 | – |
| 15. Jul 2026 | Mahboob Vaseem | Chief Financial Officer | Other | 44,118 | 0.00 | – |
| 15. Jul 2026 | Umberger Traci S | See Remarks | Other | 58,832 | 0.00 | – |
| 15. Jul 2026 | Webster Brian Daniel | See Remarks | Sell | 3,000 | 24.00 | 71,995 |
| 15. Jul 2026 | Webster Brian Daniel | See Remarks | Sell | 784 | 22.63 | 17,745 |
| 15. Jul 2026 | Webster Brian Daniel | See Remarks | Sell | 11,216 | 22.01 | 246,870 |
| 15. Jul 2026 | Webster Brian Daniel | See Remarks | Other | 176,470 | 0.00 | – |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.